Global Med Technologies(R)' Laboratory Software Licensed to Paris Area Hospital
DENVER, Jan. 5 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc. ("Global Med" or the "Company") (OTC Bulletin Board: GLOB), an international healthcare information technology company, today announced that its Inlog S.A. subsidiary has licensed its EdgeLab™ Laboratory Information Management Software (Marketed as "Labo Serveur" in France) to the Centre hospitalier intercommunal des Portes de l'Oise (Beaumont-sur-Oise Hospital) of Beaumont-sur-Oise, France. Terms of the agreement were not disclosed.
Since EdgeLab was introduced into the hospital market in 1999 as "Labo Serveur", it has become a leading laboratory information management system in Europe with more than 150 licensed laboratories. EdgeLab is connected with more than 1,000 analyzers and interchanges data with all major hospital healthcare software applications. It has a vibrant, easy-to-use Windows graphical interface in addition to a comprehensive range of laboratory functionality.
EdgeLab can be easily configured to meet the business needs of large, diverse, multi-site hospital laboratories, as well as small, single-site hospitals. The Beaumont-sur-Oise Hospital Laboratory will use EdgeLab to process over 180 patient files per day. EdgeLab will be connected to seven analyzers and interface with the Crossway Hospital Information System installed at Beaumont-sur-Oise.
Will Willman, Global Med's Sr. Vice President of Sales and Marketing EU/ME/Asia, commented, "The Beaumont-sur-Oise Hospital Laboratory chose EdgeLab for several reasons: EdgeLab interfaces well with Inlog's EdgeTrack blood bank software (not available in the U.S.) which is already installed in the hospital and it has a wide range of features important to Beaumont-sur-Oise's laboratory operation. In addition, EdgeLab was recommended by other labs in the area, the software is user-friendly, and Beaumont-sur-Oise had a very positive experience with our project managers while installing EdgeTrack."
Mr. Willman continued, "We are proud to have been chosen by Beaumont-sur-Oise Hospital Laboratory to provide them with a state-of-the-art laboratory information solution. We are looking forward to working with their superb team again."
About the Beaumont-sur-Oise Hospital
Located 45 kilometers west of Paris, The Beaumont-sur-Oise Hospital (Centre hospitalier intercommunal des Portes de l'Oise) is spread over three sites: the main site (OLS) in Beaumont sur Oise, the Olives location which is dedicated to psychiatry, and a third site located in Meru. The organization employs 1,150 staff members who work in more than 75 hospital units.
About Global Med Technologies®, Inc.
Global Med Technologies, Inc. is an international healthcare information technology company which develops regulated and non-regulated products and services for the healthcare industry. As a leading provider of blood and laboratory systems and services, Global Med's products are deployed in 20 countries and serve over 2,100 transfusion centers, blood banks and laboratory sites.
Global Med's domestic companies are Wyndgate Technologies®, a leader in software products and services for donor centers and hospital transfusion services; eDonor®, which offers web-based donor relationship management systems; Hemo-Net®, a healthcare application service provider; and PeopleMed®, Inc., which implements cost-effective software validation, consulting and compliance solutions to hospitals and donor centers.
Global Med's European subsidiary, Inlog, SA, is a leading developer of donor center and transfusion management systems as well as cellular therapy software, laboratory information systems and quality assurance medical software systems internationally.
For more information about Global Med's products and services, please call 800-996-3428 or visit www.globalmedtech.com.
This news release may include statements that constitute forward-looking statements, usually containing the words "believe," "estimate," "project," "expects" or similar expressions. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. By making these forward-looking statements, the Company undertakes no obligation to update these statements for revisions or changes after the date of this news release.
SOURCE Global Med Technologies, Inc.